Wanjia Group Holdings (HKSE:00401) Research & Development : HK$0.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Wanjia Group Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Wanjia Group Holdings's Research & Development for the six months ended in Sep. 2023 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.0 Mil.

Wanjia Group Holdings Research & Development Historical Data

The historical data trend for Wanjia Group Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanjia Group Holdings Research & Development Chart

Wanjia Group Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Research & Development

Get a 7-Day Free Trial

Wanjia Group Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Wanjia Group Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Wanjia Group Holdings (HKSE:00401) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Wanjia Group Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Wanjia Group Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanjia Group Holdings (HKSE:00401) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Wanjia Group Holdings Ltd (HKSE:00401) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

25 Canton Road, Harbour City, Suite 1801, 18th Floor, Tower 1, The Gateway, Kowloon, Hong Kong, HKG

Website

https://www.wanjia-gp.com

Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business.

Executives

Wang Jia Jun	2101 Beneficial owner
Expert Wealth Investments Limited	2201 Interest of corporation controlled by you
Grand Harbour Finance Limited	2106 Person having a security interest in shares
Yung Ka Lai	2101 Beneficial owner
Ng Kwok Fai	2201 Interest of corporation controlled by you
Wei Yang Tou Zi Fa Zhan You Xian Gong Si	2101 Beneficial owner
Li Wei	2202 Interest of your spouse
Liu Chang	2201 Interest of corporation controlled by you
Liu Yonghao	2201 Interest of corporation controlled by you
Nan Fang Xi Wang Shi Ye You Xian Gong Si	2201 Interest of corporation controlled by you
Xin Xi Wang Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Xi Zang Heng Ye Feng Shi Ye You Xian Gong Si	2201 Interest of corporation controlled by you

Wanjia Group Holdings (HKSE:00401) Headlines

No Headlines